Second to None:
- 10 year comparative study in which implantation in extraction alveoli augmented with CERASORB proved equal to implantation in natural bone.1
- In a bilateral sinus lift study, results suggest CERASORB is an equivalent graft material to autogenous bone.2
- Handling, efficacy and healing of the bone substitute were generally rated as “very good” or “good” and yielded a rate of 90% for both efficacy and tolerance.3
- Twenty-two patients with contralateral intrabony defects were treated with β-TCP CERASORB® alone or in combination with PRP. β-TCP CERASORB is a satisfactory graft material in periodontal surgery, even without PRP. 4
References
- Harel, N., et al. (2013): Long-term Results of Implants Immediately Placed into Extraction Sockets Grafted with ß-TCP: A Retrospective Study. J Oral Maxillofac Surgery 2013, 71(2): e63-e68
- Szabo G, Huys, et al. International Journal of Oral and Maxillofac Implants 2005; 20:371-381.
- Bilk, Dieter. (2007); CERASORB M in Dental Surgery: Post-Marketing Surveillance Study with 148 patients. EDI Journal 2007; 4: 40-46
- Harnack L, et al, (2009) Use of platelet-rich plasma in periodontal surgery—a prospective randomised double blind clinical trial. Clin Oral Investig. 2009 Jun: 13 (2): 179-187.